Lv5
1600 积分 2022-10-25 加入
How I reduce and treat posttransplant relapse of MDS
1个月前
已完结
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML
9个月前
已完结
Haploidentical transplantation in primary refractory/relapsed secondary versus de novo AML: from the ALWP/EBMT
1年前
已完结
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts
1年前
已完结
Cladribine‐ and decitabine‐containing conditioning regimen has a low post‐transplant relapse rate in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome
1年前
已完结
Post-transplantation cyclophosphamide is associated with increased bacterial infections
1年前
已完结
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantation
1年前
已完结
Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome
1年前
已关闭
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Chronic Leukemia Committee
1年前
已完结
皖公网安备34019202002308
